Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 10/30/2024 | $150.00 → $135.00 | Outperform → Neutral | Wedbush | |
| 10/23/2024 | $60.00 | Buy | Needham | |
| 10/22/2024 | $70.00 → $65.00 | Buy | UBS | |
| 10/21/2024 | $430.00 | Neutral → Outperform | Wedbush | |
| 10/7/2024 | $27.00 | Accumulate | Gordon Haskett | |
| 9/23/2024 | Buy → Hold | TD Cowen | ||
| 9/11/2024 | $148.00 → $156.00 | Hold → Buy | Jefferies | |
| 9/10/2024 | $300.00 | Sell | B. Riley Securities |
4 - Sleep Number Corp (0000827187) (Issuer)
4 - GameStop Corp. (0001326380) (Issuer)
4 - RH (0001528849) (Issuer)
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Q3 Net Revenue of $2.9 billion with 21.7 million Active Customers BOSTON, Nov. 1, 2024 /PRNewswire/ -- Wayfair Inc. ("Wayfair," "we," or "our") (NYSE:W), one of the world's largest destinations for the home, today reported financial results for its third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total net revenue of $2.9 billion, decreased $60 million, down 2.0% year over yearU.S. net revenue of $2.5 billion, decreased $60 million, down 2.3% year over yearInternational net revenue of $372 million and International Net Revenue Constant Currency G
COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021 Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs) Increased year-to-date free cash flow by $50 million compared with the same period last year Updated full-year 2024 adjusted EBITDA outlook to a revised ra
Virtual Annual Meeting of Stockholders Scheduled for January 24, 2025 Sally Beauty Holdings, Inc. (NYSE:SBH) ("the Company"), the leader in professional hair color, announced today that it will host a conference call and webcast on November 14, 2024, at 7:30 a.m. Central Time to discuss its fourth quarter and full year financial results. A copy of the press release announcing the fourth quarter and full year financial results is expected to be made available before the U.S. financial markets open on November 14, 2024, on the Company's website sallybeautyholdings.com/investor-relations. The earnings conference call and webcast will follow at 7:30 a.m. Central Time. This conference call an
10-Q - Wayfair Inc. (0001616707) (Filer)
8-K - Wayfair Inc. (0001616707) (Filer)
8-K - Sleep Number Corp (0000827187) (Filer)
4 - WILLIAMS SONOMA INC (0000719955) (Issuer)
4 - WILLIAMS SONOMA INC (0000719955) (Issuer)
4 - WILLIAMS SONOMA INC (0000719955) (Issuer)
Williams-Sonoma (NYSE:WSM) has outperformed the market over the past 10 years by 5.46% on an annualized basis producing an average annual return of 16.09%. Currently, Williams-Sonoma has a market capitalization of $19.44 billion. Buying $1000 In WSM: If an investor had bought $1000 of WSM stock 10 years ago, it would be worth $4,421.53 today based on a price of $151.15 for WSM at the time of writing. Williams-Sonoma's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated con
Ulta Beauty, Inc. (NASDAQ:ULTA) shares experienced a notable decline on Wednesday, driven by a downgrade from Piper Sandler and lowered price targets from multiple analysts. Why It's Moving: Piper Sandler analyst Korinne Wolfmeyer downgraded Ulta Beauty from Overweight to Neutral and reduced the price target from $494 to $404. Additionally, Wells Fargo analyst Ike Boruchow maintained an Underweight rating on Ulta Beauty and lowered the price target from $350 to $325. Earnings and Guidance Analysis: Competitive and Promotional Challenges: Piper noted Ulta Beauty faces increasing competition from Sephora, which has expanded its presence through over 1,000 store fronts within Kohl’s
Wedbush analyst Seth Basham reiterates Wayfair (NYSE:W) with a Outperform and maintains $70 price target.
Minnesota's longest tenured female public company CEO transformed mattress retailer into wellness technology company, built iconic Sleep Number brand Company also shares plans for additional Board and corporate governance changes Sleep Number Corporation (NASDAQ:SNBR) announced today that Shelly Ibach has shared her plans to retire as Chair, President and Chief Executive Officer, no later than the 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"). Pursuant to its established succession plan, the Board of Directors (the "Board") has engaged an independent executive search firm to help identify Ibach's CEO successor. To support an effective transition, Ibach will continue to s
Pitney Bowes Inc. (NYSE:PBI) ("Pitney Bowes" or the "Company"), a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the world, today announced the appointment of Lance Rosenzweig as the Company's permanent Chief Executive Officer ("CEO"), effective immediately. The Company's Board of Directors (the "Board") carried out an extensive CEO search process that was supported by a nationally recognized executive recruiting firm and included both internal and external candidates. After assessing Mr. Rosenzweig's considerable contributions as interim CEO and his track record of value creation at Pitney Bowes and at other co
SAN CARLOS, Calif., Oct. 28, 2024 /PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the addition of Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and co-founder of MedtechWomen, as a Venture Partner. Kilpatrick earned her Ph.D. from Georgia Tech in mechanical engineering with a focus in bioengineering and a minor in applied mathematics. Most recently, she was the CEO and Executive Chair of the Board at Evidation Health, a technology company that pioneered th
Wedbush downgraded Williams-Sonoma from Outperform to Neutral and set a new price target of $135.00 from $150.00 previously
Needham resumed coverage of Wayfair with a rating of Buy and set a new price target of $60.00
UBS reiterated coverage of Wayfair with a rating of Buy and set a new price target of $65.00 from $70.00 previously
SC 13G - FOOT LOCKER, INC. (0000850209) (Subject)
SC 13G/A - FOOT LOCKER, INC. (0000850209) (Subject)
SC 13G - RH (0001528849) (Subject)
Q3 Net Revenue of $2.9 billion with 21.7 million Active Customers BOSTON, Nov. 1, 2024 /PRNewswire/ -- Wayfair Inc. ("Wayfair," "we," or "our") (NYSE:W), one of the world's largest destinations for the home, today reported financial results for its third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total net revenue of $2.9 billion, decreased $60 million, down 2.0% year over yearU.S. net revenue of $2.5 billion, decreased $60 million, down 2.3% year over yearInternational net revenue of $372 million and International Net Revenue Constant Currency G
COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021 Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs) Increased year-to-date free cash flow by $50 million compared with the same period last year Updated full-year 2024 adjusted EBITDA outlook to a revised ra
Minnesota's longest tenured female public company CEO transformed mattress retailer into wellness technology company, built iconic Sleep Number brand Company also shares plans for additional Board and corporate governance changes Sleep Number Corporation (NASDAQ:SNBR) announced today that Shelly Ibach has shared her plans to retire as Chair, President and Chief Executive Officer, no later than the 2025 Annual Meeting of Shareholders (the "2025 Annual Meeting"). Pursuant to its established succession plan, the Board of Directors (the "Board") has engaged an independent executive search firm to help identify Ibach's CEO successor. To support an effective transition, Ibach will continue to s